Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Prospective Cohort Study - Registry of Patients With Hematologic Disease and COVID-19 in Russia (CHRONOS19)

NCT04422470 is registered in ClinicalTrials.gov with National Research Center for Hematology, Russia as lead sponsor.

NCT NCT04422470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04422470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Prospective Cohort Study - Registry of Patients With Hematologic Disease and COVID-19 in Russia (CHRONOS19)
Lead sponsor
National Research Center for Hematology, Russia
Phase
Observational
Overall status
Completed
Start date
June 22, 2020
Completion date
January 18, 2022
Enrollment
666 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection and hematologic diseases